ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,668,101 | +12.0% | 3,393 | -11.2% | 2.15% | +20.0% |
| Q2 2023 | $1,489,158 | +5.0% | 3,821 | +0.4% | 1.79% | -8.7% |
| Q1 2023 | $1,417,667 | -51.5% | 3,805 | -50.7% | 1.96% | -30.1% |
| Q4 2022 | $2,924,189 | +12.9% | 7,719 | +5.2% | 2.81% | +12.7% |
| Q3 2022 | $2,591,000 | -10.3% | 7,338 | -3.8% | 2.49% | -20.8% |
| Q2 2022 | $2,890,000 | -34.2% | 7,628 | -45.2% | 3.15% | +3.1% |
| Q1 2022 | $4,391,000 | -48.2% | 13,925 | -42.4% | 3.05% | -25.0% |
| Q4 2021 | $8,473,000 | +82.1% | 24,196 | +57.0% | 4.07% | +97.0% |
| Q3 2021 | $4,654,000 | +23.0% | 15,410 | +22.7% | 2.06% | +18.3% |
| Q2 2021 | $3,783,000 | +25.8% | 12,564 | +15.1% | 1.74% | -1.8% |
| Q1 2021 | $3,006,000 | +16.2% | 10,917 | +24.1% | 1.78% | -9.9% |
| Q4 2020 | $2,587,000 | – | 8,798 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |